Olaparib is effective in combination with, and as maintenance therapy after, first‐line endocrine therapy in prostate cancer cells
暂无分享,去创建一个
M. Hermann | J. Bouchal | Z. Culig | Peter D. Leitner | I. Skvortsova | J. Vrbková | F. R. Santer | Gertrud E. Feiersinger | Kristina Trattnig | Fabian Guggenberger | A. Oberhuber | Sarah Peer | F. Santer